Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 178 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies

 		Primary Immune Thrombocytopenia (ITP) Phase2 United States
Turkey
Spain
China
Czechia
Argentina
Australia
France
Germany
Italy
United Kingdom
Malaysia
Poland
Korea, Republic of
View All

Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients

 		B-Cell Acute Lymphoblastic Leukemia Phase2 United States
Netherlands

Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France

 		Breast Cancer France

Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

 		Coronary Artery Disease Phase3 United States
Spain
Belgium
Australia
India
China
United Kingdom
Hungary
Argentina
Korea, Republic of
Brazil
Ireland
Switzerland
Japan
Italy
Canada
France
Chile
View All

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

 		Oligometastatic Prostate Cancer (OMPC) Phase3 Australia
Switzerland
Israel
Japan
Canada
Singapore
United States
View All

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

 		Relapsing Multiple Sclerosis Phase3 United States
Puerto Rico
Spain
India
Greece
Slovakia
China
Poland
South Africa
Argentina
Portugal
Brazil
Romania
Italy
Canada
Turkey
France
United Kingdom
Slovenia
Japan
Mexico
Bulgaria
Croatia
Sweden
Estonia
View All

Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)

 		Polymyalgia Rheumatica Phase3 Australia

Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.

 		Glioblastoma Multiforme, Brain Neoplasms, Gastroesophageal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma Early_phase1 Germany

A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®

 		Asthma Korea, Republic of

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

 		Myeloid Leukemia, Philadelphia Positive Phase1, Phase2 United States
Greece
Thailand
China
France
Hungary
Turkey
Germany
Italy
Russian Federation
Japan
Korea, Republic of
Netherlands
Poland
View All